Physician

Ornette L Gaines, M.D.

According to 2025 Medicare claims, Ornette Gaines, M.D. (NPI: 1386613503) practices family practice in the Fayetteville-Springdale-Rogers, AR market, with the plurality of this provider's patient population coming from Washington, AR. This provider's primary affiliated billing organization is OPTIMAL PAIN AND WELLNESS (NPI: 1487920146; TIN: 26-1468338) and primary practice location at 72703-5251.

Gaines' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 313 traditional Medicare patients, billed 2,715 HCPCS/CPT codes, and received $281,379 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 10,492 prescription claims across 912 beneficiaries totaling $540,163 in drug costs, led by Xtampza Er (Oxycodone Myristate). DME data shows 24 claims. Open Payments data shows 3 records totaling $56. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $614 to $281,379. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,324 to $2,868.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$255K$509K2015 Medicare payment: $614 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $70,802 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $278,564 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $325,184 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $438,234 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $444,744 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $491,260 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $509,253 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $430,386 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $281,379 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153457$614
20162791,032$70,802
20174232,981$278,564
20184493,931$325,184
20196796,285$438,234
20206317,551$444,744
20215264,773$491,260
20224024,628$509,253
20233684,064$430,386
20243132,715$281,379

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$529K$1.1M2015 Drug cost: $181,509 (USD; Tot_Drug_Cst)2016 Drug cost: $312,656 (USD; Tot_Drug_Cst)2017 Drug cost: $648,104 (USD; Tot_Drug_Cst)2018 Drug cost: $820,467 (USD; Tot_Drug_Cst)2019 Drug cost: $1,057,450 (USD; Tot_Drug_Cst)2020 Drug cost: $1,042,195 (USD; Tot_Drug_Cst)2021 Drug cost: $887,725 (USD; Tot_Drug_Cst)2022 Drug cost: $900,880 (USD; Tot_Drug_Cst)2023 Drug cost: $857,945 (USD; Tot_Drug_Cst)2024 Drug cost: $540,163 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151562,852$181,509
20164884,740$312,656
201770611,847$648,104
201885714,031$820,467
20191,36417,698$1,057,450
20201,33919,651$1,042,195
20211,19016,483$887,725
20221,02514,869$900,880
20231,00714,869$857,945
202491210,492$540,163

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.9K$7.7K2015 Medicare payment: $7,708 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $4,533 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $1,772 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $370 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $4,495 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $1,416 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $1,063 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201515137$7,708
201629169$4,533
201713109$1,772
2018N/R34$370
20191284$4,495
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R24$1,416
2024N/R24$1,063

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0482Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms272749$194
G0481Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms68111$153
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more281908$71
80307Testing for presence of drug, by chemistry analyzers287860$61
99211Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional3939$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Xtampza ErOxycodone Myristate2005,793$84,587
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,72650,890$61,356
MovantikNaloxegol Oxalate1294,105$55,446
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen1,27237,682$49,293
Oxycodone HclOxycodone Hcl2,11762,838$44,789

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R12$875
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R12$188

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$56Collegium Pharmaceutical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ornette L. Gaines, M.D.?

Tedicare shows public-source Medicare data for Ornette L. Gaines, M.D. (NPI 1386613503), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ornette L. Gaines, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ornette L. Gaines, M.D.?

Ornette L. Gaines, M.D. is linked to OPTIMAL PAIN AND WELLNESS (billing NPI 1487920146) in the available physician profile data.

Does Ornette L. Gaines, M.D. have Open Payments data?

Ornette L. Gaines, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.